• Policy
• Janssen, granted permission to import advanced bio medicines
• by Lee, Tak-Sun Oct 21, 2021 05:14am

• InterView
• Merck will “focus on specialty care capabilities"
• by Eo, Yun-Ho Oct 21, 2021 05:14am

• Policy
• Vegzelma is the name of Celltrion's Avastin biosimilar
• by Lee, Tak-Sun Oct 21, 2021 05:14am

• Policy
• The status of clinical trials is reported annually
• by Lee, Tak-Sun Oct 21, 2021 05:14am

• Company
• Q3 exports of Biopharmas 'Good’ Diagnostic kits ‘Slow'
• by Kim, Jin-Gu Oct 21, 2021 05:13am

• Company
• Pfizer applies for reimbursement of 3rd-gen ALKi Lorviqua
• by Eo, Yun-Ho Oct 20, 2021 05:56am

• Policy
• The gov. begins research on preferential tx
• by Lee, Jeong-Hwan Oct 20, 2021 05:56am

• Company
• Moderna Korea speeds up group organization
• by Oct 20, 2021 05:56am

• Policy
• It will improve side effects caused by non-face-to-face tx
• by Lee, Jeong-Hwan Oct 20, 2021 05:56am

• Policy
• One-shot treatment Kymriah passed the cancer committee
• by Lee, Hye-Kyung Oct 20, 2021 05:55am